切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (01) : 108 -111. doi: 10.3877/cma.j.issn.1674-3946.2025.01.029.

综述

胃印戒细胞癌的临床病理特征及治疗选择的研究进展
陈浩1, 王萌1,()   
  1. 1.210008 南京,南京大学附属南京鼓楼医院普通外科
  • 收稿日期:2023-11-20 出版日期:2025-02-26
  • 通信作者: 王萌

Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach

Hao Chen1, Meng Wang1,()   

  1. 1.Department of General Surgery,Nanjing Drum Tower Hospital Affiliated to Nanjing University, Nanjing Jiangsu Province 210008,China
  • Received:2023-11-20 Published:2025-02-26
  • Corresponding author: Meng Wang
引用本文:

陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.

Hao Chen, Meng Wang. Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 108-111.

印戒细胞癌是一种特殊类型的腺癌,具有进展期恶性程度高、复发转移率高、生存预后差的特性。本文就胃印戒细胞癌的定义分类、遗传学特点、临床病理特征、早期和进展期的治疗、化疗耐药机制等方面进行了文献回顾,试图总结出胃印戒细胞癌的诊疗进展,为临床诊治提供必要的参考依据。

Sig-ring cell carcinoma is a special type of adenocarcinoma, which has the characteristics of high malignant degree in the advanced stage, high recurrence and metastasis rate, and poor survival prognosis.This article reviewed the literature on the definition and classification, genetic characteristics,clinicopathological features, early and advanced treatment, and chemotherapy resistance mechanism of gastric sig-ring cell carcinoma, in an attempt to summarize the progress of diagnosis and treatment of gastric sig-ring cell carcinoma, and provide necessary reference for clinical diagnosis and treatment.

[1]
Sentani K, Imai T, Kobayashi G, et al.Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns [J].Gastric Cancer, 2021, 24(2): 368-381.
[2]
Nagtegaal ID, Odze RD, Klimstra D, et al.The 2019 WHO classification of tumours of the digestive system[J].Histopathology, 2020, 76(2): 182-118.
[3]
Zhao B, Lu H, Luo R, et al.Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients[ J].Clin Res Hepatol Gastroenterol, 2021, 45(1): 101454.
[4]
Dal Cero M, Bencivenga M, Liu DHW, et al.Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis[ J].Cancers (Basel), 2023, 15(21):5191.
[5]
Alaggio R, Amador C, Anagnostopoulos I, et al.The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms[ J].Leukemia, 2022, 36(7): 1720-1748.
[6]
Wei Q, Gao Y, Qi C, et al.Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study[ J].Front Oncol, 2021, 11: 580545.
[7]
Drubay V, Nuytens F, Renaud F, et al.Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management[ J].World J Gastrointest Oncol, 2022, 14(8): 1406-1428.
[8]
Mariette C, Carneiro F, Grabsch HI, et al.Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma[ J].Gastric Cancer, 2019, 22(1): 1-9.
[9]
Kwon CH, Kim YK, Lee S, et al.Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes[ J].Histopathology, 2018, 72(4): 556-568.
[10]
Kumar NAN, Jose A, Usman N, et al.Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations,stage-stratified treatment approaches, and future challenges[ J].Langenbecks Arch Surg, 2022, 407(1): 87-98.
[11]
Li Y, Zhu Z, Ma F, et al.Gastric Signet Ring Cell Carcinoma:Current Management and Future Challenges[ J].Cancer Manag Res, 2020, 12: 7973-7981.
[12]
Tamura G, Sato K, Akiyama S, et al.Molecular characterization of undifferentiated-type gastric carcinoma[ J].Lab Invest, 2001,81(4): 593-598.
[13]
Soda T, Gen Y, Terasaki K, et al.Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach[ J].Sci Rep,2022, 12(1): 5050.
[14]
Shu Y, Zhang W, Hou Q, et al.Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer[ J].Nat Commun, 2018, 9(1): 2447.
[15]
Stjepanovic N, Moreira L, Carneiro F, et al.Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[ J].Ann Oncol, 2019, 30(10):1558-1571.
[16]
Van Der Post RS, Vogelaar IP, Carneiro F, et al.Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers[ J].J Med Genet,2015, 52(6): 361-374.
[17]
Hansford S, Kaurah P, Li-Chang H, et al.Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond [J].JAMA Oncol, 2015, 1(1): 23-32.
[18]
Chen JN, Wang QW, Zhang QW, et al.Poorly differentiated is more significant than signet ring cell component for lymph node metastasis in mixed-type early gastric cancer: a retrospective study from a large-volume hospital[ J].Surg Endosc, 2021, 35(4):1558-1565.
[19]
Chu Y, Mao T, Li X, et al.Predictors of Lymph Node Metastasis and Differences Between Pure and Mixed Histologic Types of Early Gastric Signet-ring Cell Carcinomas[ J].Am J Surg Pathol,2020, 44(7): 934-942.
[20]
梅郁, 朱正纲.胃印戒细胞癌的临床病理特征与外科综合治疗[J].外科理论与实践, 2021, 26(01): 79-83.
[21]
Murai K, Takizawa K, Shimoda T, et al.Effect of double-layer structure in intramucosal gastric signet-ring cell carcinoma on lymph node metastasis: a retrospective, single-center study[ J].Gastric Cancer, 2019, 22(4): 751-758.
[22]
Kerckhoffs KGP, Liu DHW, Saragoni L, et al.Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer[ J].Gastric Cancer, 2020,23(5): 765-779.
[23]
Kao YC, Fang WL, Wang RF, et al.Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer[ J].Gastric Cancer, 2019, 22(2): 255-263.
[24]
Garcia-Pelaez J, Barbosa-Matos R, Gullo I, et al.Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges[ J].Mol Oncol, 2021, 15(11): 2841-2867.
[25]
Bencivenga M, Treppiedi E, Dal Cero M, et al.The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours[ J].J Surg Oncol,2020, 121(7): 1084-1089.
[26]
Shiotsuki K, Takizawa K, Ono H.Indications of Endoscopic Submucosal Dissection for Undifferentiated Early Gastric Cancer:Current Status and Future Perspectives for Further Expansion[ J].Digestion, 2022, 103(1): 76-82.
[27]
Kim MN, Kim HK, Shim CN, et al.Tumour size is related to the curability of signet ring cell early gastric cancer with endoscopic submucosal dissection: a retrospective single centre study[ J].Dig Liver Dis, 2014, 46(10): 898-902.
[28]
Zhao X, Cai A, Xi H, et al.Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology: a meta-analysis[ J].ANZ J Surg, 2017, 87(12): 981-986.
[29]
张伟, 蔡振花.早期胃癌患者腹腔镜胃癌根治术后复发相关因素分析[J/CD].中华普外科手术学杂志(电子版), 2020,14(06): 566-568.
[30]
Kelly KJ, Selby L, Chou JF, et al.Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study[ J].Ann Surg Oncol, 2015, 22(11): 3590-3596.
[31]
常宁, 赵春临, 张红雨, 等.胃印戒细胞癌预后及手术方式的临床研究[J].临床医学研究与实践, 2018, 3(18): 10-13+28.
[32]
Jeon HK, Lee S J, Kim GH, et al.Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: short- and long-term outcomes[ J].Surg Endosc, 2018, 32(4): 1963-1970.
[33]
De Manzoni G, Verlato G, Bencivenga M, et al.Impact of superextended lymphadenectomy on relapse in advanced gastric cancer[J].Eur J Surg Oncol, 2015, 41(4): 534-540.
[34]
Mengardo V, Treppiedi E, Bencivenga M, et al.Tailored treatment for signet ring cell gastric cancer[ J].Updates Surg, 2018, 70(2):167-171.
[35]
蒋晓, 张龙, 尤玉成, 等.基于D2淋巴结清扫的两种术式治疗胃癌的近中期随访评价 [J/CD].中华普外科手术学杂志(电子版), 2021, 15(06): 650-652.
[36]
Park YK, Yoon HM, Kim YW, et al.Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer:Results From a Randomized Phase II Multicenter Clinical Trial(COACT 1001)[ J].Ann Surg, 2018, 267(4): 638-645.
[37]
Nakayama I, Shinozaki E, Sakata S, et al.Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults[ J].Cancer Sci, 2019, 110(4): 1352-1363.
[38]
Phoo NLL, Dejkriengkraikul P, Khaw-On P, et al.Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death[ J].Int J Mol Sci, 2021, 22(22):12512.
[39]
Lae Lae Phoo N, Sukhamwang A, Dejkriengkraikul P, et al.Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways[ J].Int J Mol Sci, 2022, 23(20):12066.
[1] 许革新, 何琦, 毛智军, 普彦淞, 杨淦傑, 王建华. 我国胃肿瘤外科治疗现状及发展趋势—基于CiteSpace的可视化分析[J]. 中华普通外科学文献(电子版), 2024, 18(05): 350-356.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[10] 刘海旺, 施海, 尚利峰. 不同吻合器在腹腔镜远端胃癌根治术Roux-en-Y式吻合中的应用对比[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 643-646.
[11] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[12] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[13] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[14] 仝聪, 周哲琦, 阎立昆. 食管裂孔疝合并胃食管反流病治疗现状及与胃食管结合部肿瘤的关系[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 491-493.
[15] 蒋凤茹, 朱熠林. 双腔造瘘口旁疝诊疗经验[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 534-537.
阅读次数
全文


摘要